Effector Therapeutics Company
eFFECTOR Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs known as selective translation regulator inhibitors (STRIs).
Investors
.png)
Industry:
Genomic and Epigenominc Instabillity
Estimated Revenue:
$10M to $50M
Technology:
Others
Headquarters:
United States
Employee Number:
11-50
Founded Date:
2012